- Exchange: ASE
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Starpharma Holdings Ltd
+ Add to WatchlistSPL:AU
0.8700 AUD 0.0050 0.58%As of 02:10:37 ET on 05/24/2013.
Company Profile for Starpharma Holdings Ltd (SPL)
Starpharma Holdings Limited is biotechnology company involved in the research, development and commercialization of dendrimer-based for pharmaceutical, life sciences and other applications. The Company's lead product in development is VivaGel, a microbicide gel for women, for the prevention and treatment of bacterial vaginosis adn a range of sexually transmitted diseases.
Contact Information
Starpharma Holdings Ltd
Baker Building
75 Commercial Road
Melbourne, VIC 3004
Australia
Key Executives for Starpharma Holdings Ltd (SPL)
| Jacinth K Fairley "Jackie"CEO/Executive Director | Nigel J BaadeChief Financial Officer |
| C Paul BarrettVP:Business Development | Jeremy R PaullVP:Dev & Regulatory Affairs |
| David J OwenVP:Research | Ben P RogersSecretary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page